Chemical Properties:
Package: Bottle, Cardboard Drum, 25kg/Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.Commercial Supply Dapoxetine Hydrochloride and Related Intermediates: 3-Chloropropiophenone CAS: 936-59-4 (S)-3-Amino-3-Phenylpropan-1-ol CAS: 82769-76-4 (S)-3-Amino-3-Phenylpropanoic Acid CAS: 40856-44-8 (R)-Diphenylprolinol CAS: 22348-32-9 (S)-Diphenylprolinol CAS: 112068-01-6 (S)-(-)-3-Chloro-1-Phenyl-1-Propanol CAS: 100306-34-1 Dapoxetine Hydrochloride CAS: 129938-20-1| Item | Specifications |
| Appearance | White Crystalline Powder |
| Purity | ≥99.0% |
| e.e | ≥99.5% |
| Specific Rotation [α]D20 | -7.0°~ -9.0°(C=0.3, H2O) |
| Loss on Drying | ≤0.20% |
| Residue on Ignition | ≤0.20% |
| Single Impurity | ≤0.50% |
| Total Impurities | ≤1.0% |
| Non-Animal Origin | Non-Animal Origin |
| Test Standard | Enterprise Standard |
| Usage | Chiral Compounds; Pharmaceutical Intermediates |
Description:
Specifications:
Package & Storage:
| Chemical Name | (S)-3-Amino-3-Phenylpropanoic Acid |
| Synonyms | (S)-β-Phenylalanine; (S)-3-Amino-3-Phenylpropionic Acid; H-(S)-beta-Phe-OH; L-β-Phe-OH; H-β-Phe-OH |
| CAS Number | 40856-44-8 |
| CAT Number | RF-CC113 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C9H11NO2 |
| Molecular Weight | 165.19 |
| Density | 1.198 |
| Melting Point | 216.0~224.0°C |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-3-Amino-3-Phenylpropanoic Acid (CAS: 40856-44-8) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis. (S)-3-Amino-3-Phenylpropanoic Acid (CAS: 40856-44-8) can be used in the synthesis of Dapoxetine Hydrochloride (CAS: 129938-20-1). Dapoxetine Hydrochloride (CAS: 129938-20-1) is a short-acting novel selective serotonin reuptake inhibitor marketed for the treatment of premature ejaculation in men. Premature ejaculation (PE) is the most common male sexual disorder.
